Intentional Brodifacoum Ingestion - 18/04/17
Doi : 10.1016/j.amjmed.2016.08.010
Sarah L. Anderson, PharmD a, b, Robbie S. Kattappuram, PharmD c, Joel C. Marrs, PharmD, BCPS, BCACP a, b, Nicole M. Joseph, MD b, ⁎ 
a Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora
b Department of General Internal Medicine, Denver Health Medical Center, Colo
c Department of Clinical Pharmacy, George Washington University Hospital, DC
∗Requests for reprints should be addressed to Nicole M. Joseph, MD, Department of General Internal Medicine at Denver Health Medical Center, 501 28th Street, Denver, CO 80205.Department of General Internal Medicine at Denver Health Medical Center501 28th StreetDenverCO80205
Plan
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the data and a significant role in writing the manuscript. |
© 2016
Elsevier Inc. Tous droits réservés.
Vol 130 - N° 1
P. e27-e28 - janvier 2017 Retour au numéro
Article précédent
- Paradoxical Thrombus ‘Caught in the Act’: Case Report and Review of the Literature
- Fateh Ali Tipoo Sultan, Sorcha Allen, Mohammad Sharif, Farouk Mookadam
- Neuroglycopenic Seizures: Sulfonylureas, Sulfamethoxazole, or Both?
- Umer Khan, Santhosh Seetharaman, Reshma Merchant
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?